Sunstar GUM Toothpaste Recalled for cGMP Deviation in Florida
Sunstar Guangzhou Ltd. is voluntarily recalling 260,000 tubes of GUM Toothpaste in Florida due to a cGMP deviation. The recall was initiated in February 2020.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences. The source cites a cGMP deviation without specific reports of illness or injury, fitting the Moderate category for voluntary precautionary recalls or minor labeling/process errors.
Plain-English summary
Sunstar Guangzhou Ltd. is voluntarily recalling 260,000 tubes of Sunstar GUM Toothpaste, 3 g tubes, NDC 53050-0002-01. The product was made in Japan and packed in China. The recall was initiated on February 28, 2020, and is classified as Class II by the FDA.
The reason for the recall is a cGMP (current Good Manufacturing Practice) deviation. The affected lots are 20180621 (Exp. 2020-06-21), 20180827 (Exp. 2020-08-27), and 20190115 (Exp. 2021-01-15). The distribution was limited to Florida only.
Consumers who have these products should stop using them and follow the instructions provided by the recalling firm. The recall status is currently terminated as of March 29, 2021.
The recalled product
- Product
- Sunstar GUM Toothpaste 3 g tubes, Toothpaste made in Japan, packed in China, NDC 53050-0002-01
- Manufacturer
- Sunstar Guangzhou Ltd.
- Category
- Drug — Oral Care
- Hazard
- Affected units
- 260,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: 20180621 Exp. 2020-06-21
- 20180827 Exp. 2020-08-27
- 20190115 Exp. 2021-01-15
Distribution
Distributed in 1 state:
Related recalls
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14